| |
Early Stage at Diagnosis (Stage I/II)
|
Advanced Stage at Diagnosis (Stage III/IV)
|
|---|
|
Variable
|
Controls (N = 622)
|
Cases (N = 168)
| | | | |
Cases (N = 182)
| | | | |
|---|
| |
N (%)
|
N (%)
|
OR*
|
(95% CI)
|
OR**
|
(95% CI)
|
N (%)
|
OR*
|
(95% CI)
|
OR**
|
(95% CI)
|
|---|
|
Body mass index 1 year before diagnosis (kg/m
2
)
| | | | | | | | | | | |
|
<24.9
|
119 (19.2)
|
25 (14.9)
|
1.00
|
Referent
|
1.00
|
Referent
|
26 (14.4)
|
1.00
|
Referent
|
1.00
|
Referent
|
|
25–29.9
|
157 (25.3)
|
38 (22.6)
|
1.10
|
(0.63-1.93)
|
1.18
|
(0.66-2.08)
|
50 (27.6)
|
1.33
|
(0.77-2.27)
|
1.31
|
(0.76-2.26)
|
|
30–34.9
|
157 (25.3)
|
51 (30.4)
|
1.53
|
(0.90-2.62)
|
1.56
|
(0.90-2.68)
|
51 (28.2)
|
1.46
|
(0.85-2.49)
|
1.45
|
(0.84-2.48)
|
|
> = 35
|
188 (30.3)
|
54 (32.1)
|
1.33
|
(0.78-2.26)
|
1.33
|
(0.78-2.28)
|
54 (29.8)
|
1.31
|
(0.77-2.22)
|
1.23
|
(0.72-2.09)
|
|
Missing
|
1
| | | | | |
1
| | | | |
|
Education
| | | | | | | | | | | |
|
High school or less
|
223 (35.9)
|
80 (47.6)
|
1.00
|
Referent
|
1.00
|
Referent
|
84 (46.2)
|
1.00
|
Referent
|
1.00
|
Referent
|
|
Some post-high school training
|
227 (36.6)
|
47 (28.0)
|
0.60
|
(0.40-0.89)
|
0.59
|
(0.39-0.90)
|
62 (34.1)
|
0.78
|
(0.53-1.14)
|
0.84
|
(0.56-1.25)
|
|
College or graduate degree
|
171 (27.5)
|
41 (24.4)
|
0.69
|
(0.45-1.06)
|
0.65
|
(0.41-1.04)
|
36 (19.8)
|
0.59
|
(0.38-0.93)
|
0.67
|
(0.42-1.09)
|
|
Missing
|
1
| | | | | | | | | | |
|
Annual Income
| | | | | | | | | | | |
|
< $10,000
|
130 (21.2)
|
43 (25.9)
|
1.00
|
Referent
|
1.00
|
Referent
|
37 (20.8)
|
1.00
|
Referent
|
1.00
|
Referent
|
|
$10,000 - < $25,000
|
145 (23.6)
|
41 (24.7)
|
0.85
|
(0.52-1.39)
|
0.86
|
(0.52-1.43)
|
49 (27.5)
|
1.15
|
(0.70-1.89)
|
1.19
|
(0.72-1.96)
|
|
$25,000 - < $50,000
|
131 (21.3)
|
41 (24.7)
|
0.96
|
(0.59-1.58)
|
0.96
|
(0.58-1.60)
|
43 (24.2)
|
1.17
|
(0.70-1.94)
|
1.27
|
(0.75-2.13)
|
|
$50,000 - < $75.000
|
103 (16.8)
|
23 (13.9)
|
0.68
|
(0.38-1.20)
|
0.69
|
(0.38-1.25)
|
23 (12.9)
|
0.79
|
(0.44-1.42)
|
0.91
|
(0.49-1.67)
|
|
≥ $75,000
|
105 (17.1)
|
18 (10.8)
|
0.52
|
(0.28-0.96)
|
0.54
|
(0.29-1.02)
|
26 (14.6)
|
0.90
|
(0.51-1.59)
|
1.09
|
(0.60-1.99)
|
|
Missing
|
8
|
2
| | | | |
4
| | | | |
- †Seventeen controls were excluded from this table; 14 cases excluded from the early stage cases and 17 cases excluded from advanced stage cases due to missing data for either parity or months of oral contraceptive use.
- *Age adjusted(ORs).
- **Multivariable adjusted (ORs) adjusted for age, months of oral contraceptive use, and parity.
